drugset / Trial / NCT04687800
Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery
RandomizedSingle-groupOpen-labelTreatment
Summary
To monitor intraocular pressure in glaucoma patients after cataract surgery preformed in conjunction with minimally invasive glaucoma surgery (MIGS)
Timeline
- Start
- 2020-12-01
- Primary completion
- 2022-10-24
- Completion
- 2022-10-24
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | 0.4 mg | Other |
| Comparator | Difluprednate | Small molecule | 0.05 % | Topical |